A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2018; you can also visit the original URL.
The file type is
Update on the treatment of gastrointestinal stromal tumors (GISTs): role of imatinib
Biologics : Targets & Therapy
In the last decade a tremendous amount has been learned about the biology and treatment of gastrointestinal stromal tumor (GIST). Imatinib mesylate has revolutionized the treatment of metastatic GIST. In addition, the role of imatinib in localized GIST has gained much interest and may improve patient outcomes. Additionally, research efforts aimed at understanding the biology and the molecular heterogeneity of GIST both at initial presentation and at the time of resistance to imatinib, hasdoi:10.2147/btt.s4396 fatcat:cs6pxqztgvbcjamrsyjhxoqeqm